|
Year
|
No. of studies
|
Sample size (Total)
|
HBV prevalence % (95 CI)
|
I2 (%)
|
|---|
|
PWID
|
|
≤ 2003
|
7
|
84
|
5.8 (3.5–9.4)
|
2
|
|
2004–2006
|
4
|
2093
|
8.2 (3.9–16.5)
|
2
|
|
2007–2009
|
8
|
2231
|
4.4 (3.7–5.4)
|
0
|
|
2010–2012
|
7
|
1682
|
3.9 (1.9–7.9)
|
9
|
|
2013–2015
|
4
|
845
|
2.7 (1.8–4.1)
|
0
|
|
≥ 2016
|
3
|
1434
|
3.1 (2.3–4.1)
|
0
|
|
Non-injecting PWUD
|
|
≤ 2003
|
1
|
149
|
1.3 (0.3–5.2)
|
−
|
|
2004–2006
|
3
|
430
|
3.3 (1.9–5.4)
|
0
|
|
2007–2009
|
2
|
539
|
3.0 (1.8–4.8)
|
0
|
|
2010–2012
|
2
|
252
|
1.2 (0.4–3.6)
|
0
|
|
2013–2015
|
2
|
3539
|
2.8 (2.3–3.4)
|
0
|
|
≥ 2016
|
1
|
3917
|
3.0 (2.6–3.6)
|
−
|
- Model: Random Effects Model
